Drug
Bismuth tripotassium dicitrate clinical trials
- studies test it
- 13
- open now
- 5
- in phase 3
- 1
- first study started
- 2006
Keep track of what changes. Save the bismuth tripotassium dicitrate studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Studies by the year they started
13 studies that test it; most in 2024 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 1
- Phase 4
- 6
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 12
The University of Hong Kong (2) · National Cheng-Kung University Hospital (2) · Azfar Farogh (1) · Mackay Memorial Hospital (1) · Aga Khan University (1) · Akil Al Islam (1) · Kaohsiung Medical University (1) · University Medical Centre Ljubljana (1)
Often tested with
Tested in the same studies.
Esomeprazole (10) · Metronidazole (10) · Tetracycline (8) · Furazolidone (1)
Studies
Open first, then newest update. How each study uses bismuth tripotassium dicitrate is read from its arms, and is right about nine times in ten.
Testing it · 13
- Effect of Triple Versus Quadruple Therapy for Treating Helicobacter Pylori InfectionEnrolling by invitationNot applicableAkil Al IslamNCT07010744Written as Quadruple therapy
- Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple TherapyRecruitingNot applicableKaohsiung Medical UniversityNCT07358130Written as rabeprazole, tripotassium dicitrate bismuthate, tetracycline, metronidazole
- Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with MalesEnrolling by invitationPhase 4National Cheng-Kung University HospitalNCT06509139Written as Drug: Bismuth Subcitrate 120 MG Oral Tablet
- The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori EradicationEnrolling by invitationPhase 4National Cheng-Kung University HospitalNCT04527055Written as Bismuth Subcitrate 120 MG Oral Tablet
- Bismuth Quadruple Therapy Versus Standard Triple TherapyRecruitingPhase 4University Medical Centre LjubljanaNCT06143124Written as Bismuth Subcitrate
- Comparative Effectiveness of Triple Versus Quadruple Therapy in the Treatment of Helicobacter Pylori Induced GastritisCompletedPhase 4Azfar FaroghNCT07312721Written as Quadruple Therapy
- ILTHPI - Comparison of Medicament Containing Tetracycline, Metronidazole, Bismuth Versus Amoxicillin, Metronidazole, ClarithromycinCompletedPhase 4Mackay Memorial HospitalNCT04853875Written as Tetracycline, Metronidazole, Bismuth subcitrate
- Empirical vs Tailored Therapy for H. Pylori InfectionStatus unknownNot applicableSeoul National University HospitalNCT04006340Written as quadruple therapy
- A Unique Regimen for Treatment of Helicobacter Pylori InfectionStatus unknownPhase 3Sherief Abd-ElsalamNCT03491995Written as Quadruple therapy
- A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole Monotherapy In Treatment Of Subjects With Nonsteroidal Anti-Inflammatory Drugs (NSAID)-Induced GastropathyTerminatedPhase 4Astellas Pharma Europe B.V.NCT02788123Written as bismuth tripotassium dicitrate
- Five Days Quadruple and Clarithromycin Containing Triple Therapy as Treatment for Helicobacter Pylori EradicationCompletedNot applicableThe University of Hong KongNCT01306786Written as Quadruple therapy
- Quadruple Versus Sequential Therapy for Helicobacter Pylori EradicationCompletedNot applicableThe University of Hong KongNCT01760824Written as Quadruple therapy
- Quadruple Therapy for Triple Therapy Resistant Helicobacter Pylori InfectionCompletedNot applicableAga Khan UniversityNCT00520949Written as Cebes (colloidal bismuth subcitrate)
Given in every arm · 3 — bismuth tripotassium dicitrate is usual care beside what is tested
- Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori EradicationNot yet recruitingNot applicableUniversity of Medicine and Pharmacy at Ho Chi Minh CityNCT07746934Written as Bismuth Subcitrate
- Non-invasive Test-guided Tailored Therapy Versus Empiric Treatment for Helicobacter Pylori Infection.Status unknownPhase 3University of BariNCT04107194Written as Bismuth Subcitrate
- Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored TherapyStatus unknownPhase 4Sir Run Run Shaw HospitalNCT02894268Written as Colloidal Bismuth Subcitrate
As the comparator · 2 — what is tested is compared with bismuth tripotassium dicitrate
- Bismuth Quadruple Therapy Versus Modified Bismuth Therapy for Helicobacter PyloriCompletedPhase 3Reham Abdelkader ElkhoulyNCT07810985Written as Quadruple therapy
- A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly PatientsStatus unknownPhase 4Shandong UniversityNCT04101708Written as Lansoprazole, Amoxicillin,Clarithromycin and Bismuth subcitrate
Codes
What other systems call bismuth tripotassium dicitrate · ClinicalTrials.gg INT002259
- MeSH (NLM) C002791bismuth tripotassium dicitrateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) HS813P8QPXBISMUTH SUBCITRATEConfirmed FDA, NLM
- RxNorm 47181One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C002791 | bismuth tripotassium dicitrate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | HS813P8QPX | BISMUTH SUBCITRATE | Confirmed FDA, NLM |
| RxNorm | 47181 | — | One source FDA |
Also registered as bismuth citrate (UNII N04867Y76N).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.